Skip to content

What Orphan Drug Companies’ R&D Officiers Are Ranked In The Top 20 By Annual Compensation ?

January 16, 2013

In the January 2013 issue of the journal Nature Biotechnology, an article titled, “Rising Compensation for Biotech R&D Officers”, discusses the trend in biotechnology of th e steady increase in compensation to the industry’s executives.

The article’s analysis is based on the 2013 BioWorld Executive Compensation Report, that “tracks the annual compensation for biopharmaceutical executives at 258 companies (including 55 non-US companies)” based on SEC filings. The focus of the article is on the compensation awarded to R&D officers.

Table 1 (“Biotech R&D officers by annual compensation”) ranks the top 20 R&D officer earners by annual compensation.  The top 20 earners had total annual compensation of anywhere from $662,000 to $2.55 million in the 2011 fiscal year. Orphan drug companies listed are : Alexion Pharmaceuticals, Biogen Idec, Vertex Pharmaceuticals, Onyx Pharmaceuticals, Ariad Pharmaceuticals, and several others.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: